Pediatrics Doctors in Oak Creek, CO Accepting Medicare
1 Pediatrics doctors found. Showing 1 - 1
 Denise Maureen Clark, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 24690 Bench Ln, Oak Creek, CO 80467 Phone: 970-879-7241 |
News Archive
AnaptysBio, Roche sign agreement for development of novel antibody therapeutics
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has signed an agreement with Roche for the development of novel antibody therapeutics.
Medco second-quarter GAAP diluted EPS increases 20.3% to $0.77
Medco Health Solutions, Inc. today reported second-quarter 2010 GAAP diluted EPS of $0.77, up 20.3 percent compared to $0.64 for the second quarter of 2009. Adjusting for the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, second-quarter 2010 diluted earnings per share increased 20.3 percent to $0.83, from $0.69 in the second quarter of 2009.
Medical schools scramble to address doctor shortage
The Wall Street Journal: "Proponents of the new health-care law say it does attempt to address the physician shortage. The law offers sweeteners to encourage more people to enter medical professions, and a 10% Medicare pay boost for primary-care doctors. … Meanwhile, a number of new medical schools have opened around the country recently."
Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers
A simple, ultrasensitive microRNA sensor developed and tested by researchers from the schools of science and medicine at Indiana University-Purdue University Indianapolis and the Indiana University Melvin and Bren Simon Cancer Center holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Generex begins testing new vaccine for breast cancer patients
Generex Biotechnology Corporation announced today that the first patients had received a novel therapeutic vaccine developed by its wholly owned subsidiary, Antigen Express as part of the Company's Phase I Trial. The Trial will include between 16 and 24 patients.
› Verified 5 days ago